As detailed in the Price Disclosure Reductions (2023 April cycle) the Department of Health and Aged Care have advised the Take Home Naloxone (THN) Program has been updated to include new amounts payable for injectable forms of naloxone. This includes Naloxone Juno, and Naloxone hydrochloride (DBL). These price changes will come into effect from 1 April 2023.

Any claims submitted with a date of supply on or after 1 April 2023 will be paid under these new amounts, which can be found on the THN webpage and in the THN Program Rules.

Any claims submitted with a date of supply on or before 31 March 2023 will be paid under the pricing arrangements that were in effect at the time of the supply (i.e. before the 1 April 2023 price changes). Previous pricing arrangements can be found in the Program Rules.

As per existing Program Rules, Authorised Alternative Suppliers do not receive payment for supply of naloxone products under the THN Program.